Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of visual information to the brain. Currently, the only available therapies target the lowering of intraocular pressure, but many patients conti...
Main Authors: | James R. Tribble, Flora Hui, Melissa Jöe, Katharina Bell, Vicki Chrysostomou, Jonathan G. Crowston, Pete A. Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/2/295 |
Similar Items
-
Nicotinamide treatment robustly protects from inherited mouse glaucoma
by: Pete A. Williams, et al.
Published: (2018-01-01) -
Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma
by: Simon W. M. John, et al.
Published: (2017-04-01) -
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection
by: Tim J. Enz, et al.
Published: (2021-08-01) -
Neuroprotection in Glaucoma: NAD<sup>+</sup>/NADH Redox State as a Potential Biomarker and Therapeutic Target
by: Bledi Petriti, et al.
Published: (2021-06-01) -
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
by: James R. Tribble, et al.
Published: (2021-07-01)